• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Envoke

To add a bio or update company history, please click update information.

News from Envoke

    Envoke lands £1.6m from VCs for lab equipment training and maintenance softwareEnvoke lands £1.6m from VCs for lab equipment training and maintenance software
    Envoke
    12 May 2026

    Envoke lands £1.6m from VCs for lab equipment training and maintenance software

    Envoke develops software that creates virtual replicas of laboratory equipment for remote training, troubleshooting and maintenance. The platform helps healthcare providers and equipment manufacturers reduce downtime, improve staff training and cut servicing costs.

    Envoke raises £1m seed extension from Mercia to expand virtual training platform for lab staffEnvoke raises £1m seed extension from Mercia to expand virtual training platform for lab staff
    Envoke
    19 May 2025

    Envoke raises £1m seed extension from Mercia to expand virtual training platform for lab staff

    Envoke builds virtual training software for laboratory equipment, allowing staff to learn, practise and troubleshoot using realistic digital simulations and remote support tools.

Envoke
  • Life Sciences
  • Leeds, United Kingdom
  • £2.6m
  • envoke-demos.com
  • Update Information

More venture news

  • Mironid raises a £34m Series B including £8.4m from Scottish National Investment Bank to advance small molecule treatments for kidney diseases
    Mironid
    5 Aug 2026

    Mironid raises a £34m Series B including £8.4m from Scottish National Investment Bank to advance small molecule treatments for kidney diseases

    Series BLife Sciences
  • Qureight lands £15m Series B led by Molten Ventures to bring AI imaging to clinical trials for lung and heart disease
    Qureight
    29 Jul 2026

    Qureight lands £15m Series B led by Molten Ventures to bring AI imaging to clinical trials for lung and heart disease

    Series BLife Sciences
  • Healome Therapeutics raises £2m to advance eye-drop matrix technology treating dry eye and ocular surface disease
    Healome Therapeutics
    7 Jul 2026

    Healome Therapeutics raises £2m to advance eye-drop matrix technology treating dry eye and ocular surface disease

    SeedLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn